CY4 Fundamental Analysis - CY4GATE SPA

Fundamental Rating

Overall CY4 gets a fundamental rating of 3 out of 10. We evaluated CY4 against 101 industry peers in the Software industry. While CY4 seems to be doing ok healthwise, there are quite some concerns on its profitability. CY4 is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CY4 has reported negative net income.

CY4 had a positive operating cash flow in the past year.

In multiple years CY4 reported negative net income over the last 5 years.

In multiple years CY4 reported negative operating cash flow during the last 5 years.

1.2 Ratios

CY4 has a Return On Assets of -9.19%. This is in the lower half of the industry: CY4 underperforms 75.25% of its industry peers.

CY4's Return On Equity of -17.68% is on the low side compared to the rest of the industry. CY4 is outperformed by 69.31% of its industry peers.

		Industry Rank	Sector Rank
ROA	-9.19%
ROE	-17.68%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 48.18%, CY4 is not doing good in the industry: 70.30% of the companies in the same industry are doing better.

CY4's Gross Margin has been stable in the last couple of years.

The Profit Margin and Operating Margin are not available for CY4 so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	48.18%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.65%

GM growth 5Y-0.54%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CY4 does not have a ROIC to compare to the WACC, probably because it is not profitable.

There is no outstanding debt for CY4. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CY4 has an Altman-Z score of 1.12. This is a bad value and indicates that CY4 is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 1.12, CY4 is not doing good in the industry: 72.28% of the companies in the same industry are doing better.

CY4 has a debt to FCF ratio of 5.51. This is a neutral value as CY4 would need 5.51 years to pay back of all of its debts.

CY4 has a Debt to FCF ratio (5.51) which is in line with its industry peers.

A Debt/Equity ratio of 0.29 indicates that CY4 is not too dependend on debt financing.

CY4 has a Debt to Equity ratio (0.29) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.29
Debt/FCF	5.51
Altman-Z	1.12

ROIC/WACCN/A

WACC8.39%

2.3 Liquidity

CY4 has a Current Ratio of 1.61. This is a normal value and indicates that CY4 is financially healthy and should not expect problems in meeting its short term obligations.

CY4 has a Current ratio of 1.61. This is in the better half of the industry: CY4 outperforms 62.38% of its industry peers.

CY4 has a Quick Ratio of 1.59. This is a normal value and indicates that CY4 is financially healthy and should not expect problems in meeting its short term obligations.

CY4's Quick ratio of 1.59 is fine compared to the rest of the industry. CY4 outperforms 64.36% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.61
Quick Ratio	1.59

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CY4 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.72%, which is quite impressive.

Looking at the last year, CY4 shows a quite strong growth in Revenue. The Revenue has grown by 13.37% in the last year.

Measured over the past years, CY4 shows a very strong growth in Revenue. The Revenue has been growing by 59.24% on average per year.

EPS 1Y (TTM)21.72%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%5.3%

Revenue 1Y (TTM)13.37%

Revenue growth 3Y61.94%

Revenue growth 5Y59.24%

Sales Q2Q%9.32%

3.2 Future

The Earnings Per Share is expected to grow by 38.86% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 7.57% on average over the next years.

EPS Next Y49.5%

EPS Next 2Y54.95%

EPS Next 3Y38.86%

EPS Next 5YN/A

Revenue Next Year7.97%

Revenue Next 2Y8.2%

Revenue Next 3Y7.57%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CY4 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

With a Price/Forward Earnings ratio of 51.49, CY4 can be considered very expensive at the moment.

The rest of the industry has a similar Price/Forward Earnings ratio as CY4.

CY4 is valuated expensively when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	51.49

4.2 Price Multiples

CY4's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CY4 is more expensive than 62.38% of the companies in the same industry.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CY4 indicates a rather cheap valuation: CY4 is cheaper than 85.15% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	14.96
EV/EBITDA	53.12

4.3 Compensation for Growth

CY4's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

A more expensive valuation may be justified as CY4's earnings are expected to grow with 38.86% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y54.95%

EPS Next 3Y38.86%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CY4 does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CY4GATE SPA

BIT:CY4 (9/12/2025, 7:00:00 PM)

5.2

+0.13 (+2.56%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners13.91%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap122.56M

Analysts86.67

Price Target5.92 (13.85%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)4.5%

PT rev (3m)4.5%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-7.23%

EPS NY rev (3m)-7.23%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	51.49
P/S	1.2
P/FCF	14.96
P/OCF	10.4
P/B	1.24
P/tB	6.84
EV/EBITDA	53.12

EPS(TTM)-0.68

EYN/A

EPS(NY)0.1

Fwd EY1.94%

FCF(TTM)0.35

FCFY6.69%

OCF(TTM)0.5

OCFY9.61%

SpS4.34

BVpS4.2

TBVpS0.76

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-9.19%
ROE	-17.68%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	48.18%
FCFM	8.01%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.65%

GM growth 5Y-0.54%

F-ScoreN/A

Asset Turnover0.54

Health

		Industry Rank	Sector Rank
Debt/Equity	0.29
Debt/FCF	5.51
Debt/EBITDA	10.26
Cap/Depr	17.12%
Cap/Sales	3.5%
Interest Coverage	N/A
Cash Conversion	422.73%
Profit Quality	N/A
Current Ratio	1.61
Quick Ratio	1.59
Altman-Z	1.12

F-ScoreN/A

WACC8.39%

ROIC/WACCN/A

Cap/Depr(3y)19.8%

Cap/Depr(5y)17.04%

Cap/Sales(3y)4.99%

Cap/Sales(5y)3.77%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)21.72%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%5.3%

EPS Next Y49.5%

EPS Next 2Y54.95%

EPS Next 3Y38.86%

EPS Next 5YN/A

Revenue 1Y (TTM)13.37%

Revenue growth 3Y61.94%

Revenue growth 5Y59.24%

Sales Q2Q%9.32%

Revenue Next Year7.97%

Revenue Next 2Y8.2%

Revenue Next 3Y7.57%

Revenue Next 5YN/A

EBIT growth 1Y-32.18%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year3400%

EBIT Next 3Y258.31%

EBIT Next 5YN/A

FCF growth 1Y-50.75%

FCF growth 3YN/A

FCF growth 5Y87.64%

OCF growth 1Y-42.43%

OCF growth 3YN/A

OCF growth 5Y43.36%

CY4GATE SPA (CY4.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens